<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016117"><a href="http://purl.obolibrary.org/obo/MONDO_0016117">MONDO:0016117</a></h3>
<p><strong>Label:</strong> muscular lipidosis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009282">MONDO:0009282</a> (multiple acyl-CoA dehydrogenase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0020504">MONDO:0020504</a> (genetic recurrent myoglobinuria), <a href="http://purl.obolibrary.org/obo/MONDO_0016810">MONDO:0016810</a> (autosomal recessive progressive external ophthalmoplegia), <a href="http://purl.obolibrary.org/obo/MONDO_0015611">MONDO:0015611</a> (neutral lipid storage disease), <a href="http://purl.obolibrary.org/obo/MONDO_0010892">MONDO:0010892</a> (mitochondrial myopathy and sideroblastic anemia), <a href="http://purl.obolibrary.org/obo/MONDO_0018002">MONDO:0018002</a> (adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0008003">MONDO:0008003</a> (autosomal dominant progressive external ophthalmoplegia), <a href="http://purl.obolibrary.org/obo/MONDO_0011835">MONDO:0011835</a> (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0008722">MONDO:0008722</a> (short chain acyl-CoA dehydrogenase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0013028">MONDO:0013028</a> (adenosine monophosphate deaminase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0009637">MONDO:0009637</a> (mitochondrial myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0015515">MONDO:0015515</a> (carnitine palmitoyltransferase II deficiency),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_26792">Orphanet:26792</a>, <a href="http://purl.obolibrary.org/obo/OMIM_600462">OMIM:600462</a>, <a href="http://purl.obolibrary.org/obo/OMIM_268200">OMIM:268200</a>, <a href="http://www.orpha.net/ORDO/Orphanet_165">Orphanet:165</a>, <a href="http://purl.obolibrary.org/obo/OMIM_157640">OMIM:157640</a>, <a href="http://www.orpha.net/ORDO/Orphanet_254881">Orphanet:254881</a>, <a href="http://purl.obolibrary.org/obo/OMIM_251900">OMIM:251900</a>, <a href="http://purl.obolibrary.org/obo/OMIM_607459">OMIM:607459</a>, <a href="http://www.orpha.net/ORDO/Orphanet_254886">Orphanet:254886</a>, <a href="http://purl.obolibrary.org/obo/OMIM_617069">OMIM:617069</a>, <a href="http://purl.obolibrary.org/obo/OMIM_500011">OMIM:500011</a>, <a href="http://purl.obolibrary.org/obo/OMIM_600649">OMIM:600649</a>, <a href="http://www.orpha.net/ORDO/Orphanet_26791">Orphanet:26791</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616479">OMIM:616479</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613561">OMIM:613561</a>, <a href="http://purl.obolibrary.org/obo/OMIM_255110">OMIM:255110</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610131">OMIM:610131</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612874">OMIM:612874</a>, <a href="http://purl.obolibrary.org/obo/OMIM_550500">OMIM:550500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99845">Orphanet:99845</a>, <a href="http://www.orpha.net/ORDO/Orphanet_206966">Orphanet:206966</a>, <a href="http://purl.obolibrary.org/obo/OMIM_231680">OMIM:231680</a>, <a href="http://www.orpha.net/ORDO/Orphanet_45">Orphanet:45</a>, <a href="http://www.orpha.net/ORDO/Orphanet_157">Orphanet:157</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608836">OMIM:608836</a>, <a href="http://www.orpha.net/ORDO/Orphanet_254892">Orphanet:254892</a>, <a href="http://purl.obolibrary.org/obo/OMIM_201470">OMIM:201470</a>, <a href="http://www.orpha.net/ORDO/Orphanet_329336">Orphanet:329336</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609283">OMIM:609283</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613077">OMIM:613077</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615511">OMIM:615511</a>, <a href="http://www.orpha.net/ORDO/Orphanet_70595">Orphanet:70595</a>, <a href="http://purl.obolibrary.org/obo/OMIM_258450">OMIM:258450</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2598">Orphanet:2598</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609286">OMIM:609286</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 58.14%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 58.14%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 58.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 58.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) 57.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 57.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) 57.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 57.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 56.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0011805">HP:0011805</a> (Abnormality of muscle morphology) 56.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) 56.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 56.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 56.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0011805">HP:0011805</a> (Abnormality of muscle morphology) 56.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0003800">HP:0003800</a> (Muscle abnormality related to mitochondrial dysfunction) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 56.16%</li>
</ul>
</body>
</html>
